Sophia Genetics SOPH
$6.23 −$0.45 (-6.74%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $6.23 0.00%
Open$6.51
Prev close$6.68
Day range$6.16 – $6.88
Volume827.7K
Market cap$533.65M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$24.27M+24.7% YoY
Operating profit-$17.82M+0.2% YoY
Net profit-$20.27M-1.3% YoY
Diluted EPS-$0.24+20.0% YoY
Free cash flow-$11.80M-2.7% YoY
Operating cash flow-$9.48M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin66.4%
Operating margin-81.0%
Net margin-89.2%
Return on equity-125.7%
Return on assets-46.6%
Return on invested capital-60.9%
Current ratio2.29
Liabilities / assets63.0%
Cash & investments$93.65M
Total debt$58.35M
Net cash (debt)$35.30M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $24.27M | $23.31M | $21.69M | $77.27M | $21.71M |
| Total Operating Revenue | $24.27M | $23.31M | $21.69M | $77.27M | $21.71M |
| Cost of Revenue | $8.33M | $8.25M | $6.94M | $25.19M | $7.02M |
| Gross Profit | $15.93M | $15.06M | $14.75M | $52.08M | $14.69M |
| Operating Expense | $33.76M | $35.11M | $32.03M | $122.98M | $33.21M |
| Selling and Admin Expenses | $25.46M | $26.39M | $22.57M | $86.07M | $22.04M |
| -Selling & Marketing Expense | $10.58M | $11.19M | $8.81M | $34.89M | $8.65M |
| -General & Admin Expense | $14.89M | $15.20M | $13.76M | $51.18M | $13.39M |
| Research & Development | $8.30M | $8.73M | $9.46M | $34.22M | $8.54M |
| Operating Profit | -$17.82M | -$20.05M | -$17.28M | -$70.91M | -$18.52M |
| Net Non-Operating Interest Income (Expense) | -$1.17M | -$1.39M | -$1.38M | -$2.68M | -$1.29M |
| Non-Operating Interest Income | $451,000.00 | $231,000.00 | $289,000.00 | $1.87M | $381,000.00 |
| Non-Operating Interest Expense | $1.62M | $1.62M | $1.67M | $4.55M | $1.67M |
| Other Income (Expense) | -$967,000.00 | -$836,000.00 | -$408,000.00 | -$3.90M | $234,000.00 |
| Gain on Sale of Security | -$967,000.00 | -$836,000.00 | -$408,000.00 | -$3.90M | $234,000.00 |
| Pretax Profit | -$19.96M | -$22.28M | -$19.07M | -$77.49M | -$19.57M |
| Tax | $314,000.00 | $78,000.00 | $253,000.00 | $1.51M | -$395,000.00 |
| Net Profit | -$20.27M | -$22.36M | -$19.32M | -$79.00M | -$19.18M |
| Profit from Continuing Operations | -$20.27M | -$22.36M | -$19.32M | -$79.00M | -$19.18M |
| Net Income to Parent Company | -$20.27M | -$22.36M | -$19.32M | -$79.00M | -$19.18M |
| Net Income to Common Stockholders | -$20.27M | -$22.36M | -$19.32M | -$79.00M | -$19.18M |
| Basic EPS | -$0.24 | -$0.30 | -$0.27 | -$1.17 | -$0.28 |
| Diluted EPS | -$0.24 | -$0.30 | -$0.27 | -$1.17 | -$0.28 |
| Other Operating Expenses | – | -$5,000.00 | – | $86,000.00 | $17,000.00 |
| Depreciation & Amortization & Depletion | – | – | – | $2.61M | – |
| -Depreciation & Amortization | – | – | – | $2.61M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $184.73M | $198.36M | $157.00M | $163.03M | $163.03M |
| Total Current Assets | $125.63M | $137.29M | $95.81M | $99.08M | $99.08M |
| Cash and Cash Equivalents & Short-Term Investments | $93.65M | $107.67M | $65.39M | $70.29M | $70.29M |
| -Cash and Cash Equivalents | $93.65M | $107.67M | $65.39M | $70.29M | $70.29M |
| Receivables | $16.73M | $14.11M | $14.31M | $16.53M | $16.53M |
| -Accounts Receivable | $13.67M | $12.12M | $13.54M | $14.40M | $14.40M |
| -Other Receivables | $3.38M | $2.25M | $1.03M | $1.10M | $1.10M |
| -Receivables Adjustments Allowances | -$319,000.00 | -$263,000.00 | -$257,000.00 | -$366,000.00 | -$366,000.00 |
| Inventory | $7.16M | $7.08M | $7.09M | $6.35M | $6.35M |
| Other Current Assets | $8.09M | $8.43M | $9.02M | $758,000.00 | $758,000.00 |
| Total Non-Current Assets | $59.10M | $61.07M | $61.18M | $63.95M | $63.95M |
| Net PPE | $14.52M | $15.94M | $16.80M | $18.05M | $18.05M |
| -Gross PPE | $14.52M | $15.94M | $16.80M | $25.91M | $25.91M |
| Goodwill and Other Intangible Assets | $35.85M | $36.16M | $35.82M | $35.89M | $35.89M |
| Non-Current Deferred Assets | $1.64M | $1.77M | $1.81M | $2.03M | $2.03M |
| Other Non-Current Assets | $7.10M | $7.20M | $6.75M | – | – |
| Total Liabilities | $116.30M | $115.24M | $111.31M | $115.89M | $115.89M |
| Total Current Liabilities | $54.92M | $51.08M | $46.60M | $50.53M | $50.53M |
| Payables | $10.28M | $11.90M | $12.67M | $8.96M | $8.96M |
| -Accounts Payable | $10.28M | $11.90M | $12.67M | $5.32M | $5.32M |
| Current Accrued Expenses | $22.62M | $18.70M | $13.44M | $4.88M | $4.88M |
| Short-Term Debt and Capital Lease Obligation | $2.69M | $2.72M | $2.71M | $2.70M | $2.70M |
| -Current Capital Lease Obligation | $2.69M | $2.72M | $2.71M | $2.70M | $2.70M |
| Current Deferred Liabilities | $16.05M | $15.62M | $15.95M | $16.72M | $16.72M |
| Other Current Liabilities | $3.28M | $2.14M | $1.83M | $1.41M | $1.41M |
| Total Non-Current Liabilities | $61.38M | $64.16M | $64.71M | $65.36M | $65.36M |
| Long Term Debt and Capital Lease Obligation | $58.35M | $59.11M | $59.71M | $60.32M | $60.32M |
| -Long Term Debt | $48.15M | $48.00M | $47.84M | $47.73M | $47.73M |
| -Long Term Capital Lease Obligation | $10.21M | $11.11M | $11.87M | $12.59M | $12.59M |
| Employee Benefits | $1.75M | $3.82M | $4.10M | $4.16M | $4.16M |
| Other Non-Current Liabilities | $1.28M | $1.23M | $902,000.00 | $876,000.00 | $876,000.00 |
| Total Equity | $68.43M | $83.12M | $45.69M | $47.15M | $47.15M |
| Stockholders' Equity | $68.43M | $83.12M | $45.69M | $47.15M | $47.15M |
| Capital Stock | $4.81M | $4.81M | $4.81M | $4.81M | $4.81M |
| -Common Stock | $4.81M | $4.81M | $4.81M | $4.81M | $4.81M |
| Additional Paid-In Capital | $543.57M | $542.66M | $488.42M | $473.68M | $473.68M |
| Retained Earnings | -$581.23M | -$560.95M | -$538.60M | -$519.28M | -$519.28M |
| Less: Treasury Stock | -$151,000.00 | -$183,000.00 | -$1.01M | -$1.22M | -$1.22M |
| Gains/Losses Not Affecting Retained Earnings | $101.42M | $96.78M | $92.06M | $89.15M | $89.15M |
| -Taxes Receivable | – | – | – | $1.39M | $1.39M |
| Prepaid Assets | – | – | – | $3.15M | $3.15M |
| Current Deferred Assets | – | – | – | $2.00M | $2.00M |
| -Accumulated Depreciation | – | – | – | -$7.86M | -$7.86M |
| Investments and Advances | – | – | – | $1.98M | $1.98M |
| -Long Term Equity Investment | – | – | – | $1.98M | $1.98M |
| Non Current Accounts Receivables | – | – | – | $4.01M | $4.01M |
| Non-Current Prepaid Assets | – | – | – | $2.00M | $2.00M |
| -Goodwill | – | – | – | $9.56M | $9.56M |
| -Other Intangible Assets | – | – | – | $26.34M | $26.34M |
| -Total Tax Payable | – | – | – | $805,000.00 | $805,000.00 |
| -Other Payable | – | – | – | $2.84M | $2.84M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$9.48M | -$7.69M | -$15.12M | -$35.89M | -$8.14M |
| Net cash flow from continuing operations | -$9.48M | -$7.69M | -$15.12M | -$35.89M | -$8.14M |
| Net Income from Continuing Operations | -$19.96M | -$22.28M | -$19.07M | -$77.49M | -$19.57M |
| Gain/Loss from Continuing Operations | $1.14M | $314,000.00 | $95,000.00 | $497,000.00 | -$90,000.00 |
| Depreciation & Depletion & Amortization | $2.83M | $2.91M | $2.75M | $9.53M | $2.44M |
| Deferred Tax | -$170,000.00 | -$268,000.00 | -$173,000.00 | -$977,000.00 | -$225,000.00 |
| Other Non-Cash Items | $1.86M | $1.93M | $1.43M | $5.13M | $118,000.00 |
| Change in Working Capital | $324,000.00 | $4.81M | -$3.48M | $10.71M | $5.10M |
| -Change in Receivables | -$2.94M | $120,000.00 | $469,000.00 | -$6.60M | -$6.63M |
| -Change in Inventory | -$382,000.00 | -$256,000.00 | -$867,000.00 | $46,000.00 | $211,000.00 |
| -Change in Prepaid Assets | -$24,000.00 | $439,000.00 | $189,000.00 | $334,000.00 | -$1.73M |
| -Change in Payables and Accrued Expense | $3.67M | $4.50M | -$3.28M | $16.93M | $13.25M |
| Net cash flow from investing | -$1.89M | -$2.47M | -$2.58M | -$8.67M | -$3.50M |
| Net Cash Flow from Continuing Investing Activities | -$1.89M | -$2.47M | -$2.58M | -$8.67M | -$3.50M |
| Capital Expenditure | -$2.59M | -$2.58M | -$1.96M | -$7.94M | -$2.24M |
| Net PPE Purchase and Sale | $274,000.00 | -$148,000.00 | -$878,000.00 | -$574,000.00 | -$338,000.00 |
| Net Intangibles Purchase and Sale | $0.00 | $32,000.00 | -$32,000.00 | -$108,000.00 | $115,000.00 |
| Financing Cash Flow | -$2.03M | $53.99M | $13.04M | $30.18M | -$385,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$2.03M | $53.99M | $13.04M | $30.18M | -$385,000.00 |
| Net Issuance Payments Of Debt | -$624,000.00 | -$632,000.00 | -$569,000.00 | $32.69M | -$477,000.00 |
| Net Common Stock Issuance | -$597,000.00 | $55.22M | $14.50M | $1.09M | $1.09M |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $968,000.00 | $770,000.00 | $463,000.00 | $346,000.00 | $147,000.00 |
| Ending Cash Balance | $93.65M | $107.67M | $65.39M | $70.29M | $70.29M |
| Net Change in Cash | -$13.39M | $43.83M | -$4.66M | -$14.39M | -$12.02M |
| Beginning Cash Balance | $107.67M | $65.39M | $70.29M | $80.23M | $81.61M |
| Effect of Exchange Rate Changes | -$621,000.00 | -$1.56M | -$238,000.00 | $4.45M | $703,000.00 |
| Free Cash Flow | -$11.80M | -$10.39M | -$17.99M | -$44.51M | -$10.60M |
| Net Business Purchase and Sale | – | – | – | -$1.89M | – |
| Net Investment Purchase and Sale | – | – | – | $0.00 | $493,000.00 |
No comments yet — be the first to weigh in on SOPH.
Sign in to join the discussion.